This has prompted an examination of all aspects of the biomedical research and development process, as companies try to cut costs and improve efficiency and productivity. The result has been corporate mergers, reorganizations, and tens of thousands of job losses in the industry.
近几年来，制药业的新药品开发进程滞缓，生产力低下，对此，人们给予了极大的关注。作为目前大型制药公司赖以开发新药品的渠道，生物科技公司也受到这种创新危机的影响。